Professional Quality of Life in German Mental Health Nursing

February 6, 2024 updated by: Moritz Petzold, Charite University, Berlin, Germany

Professional Quality of Life in Nurses Working With Patients With Mental Disorders in Germany

The purpose of this study is to assess professional quality of life in German nurses working with patients with mental disorders.

Study Overview

Detailed Description

The purpose of this study is to assess professional quality of life, which includes compassion satisfaction, burnout and secondary traumatization in nurses, working with patients with mental disorders, in Germany.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 10117
        • Charité Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapie - Charité Campus Mitte

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Nurses that currently work with patients with mental disorders in Germany.

Description

Inclusion Criteria:

  • Nurse
  • Currently working with patients with mental disorders
  • At least 18 years old
  • Sufficient German skills for answering the questionnaire

Exclusion Criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Nurses working with patients with mental disorders
Nurses in Germany currently working with patients with mental disorders
Online questionnaire via SoSciSurvey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compassion Satisfaction
Time Frame: 1 day
Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Compassion Satisfaction" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher compassion satisfaction)
1 day
Burnout
Time Frame: 1 day
Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Burnout" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher level of burnout)
1 day
Secondary Traumatization
Time Frame: 1 day
Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL) - German Version - Subscale "Secondary Traumatization" (Minimum: 10 - Maximum: 50 - Higher scores mean a higher level of secondary traumatization)
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Moritz B Petzold, Dr., Charité Universitätsmedizin Berlin- Charité Campus Mitte - Department for Psychiatry and Psychotherapy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2020

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

December 12, 2019

First Submitted That Met QC Criteria

December 12, 2019

First Posted (Actual)

December 16, 2019

Study Record Updates

Last Update Posted (Estimated)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout, Professional

Clinical Trials on Online questionnaire

3
Subscribe